Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIVEC vs GLOFITAMAB-GXBM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLIVEC vs GLOFITAMAB-GXBM: Safety Overview

Metric GLIVEC GLOFITAMAB-GXBM
Total FAERS Reports 995 498
Deaths Reported 769 175
Death Rate 77.3% 35.1%
Hospitalizations 131 113
Average Patient Age 51.9 yrs 60.0 yrs
% Female Patients N/A 36.2%
Marketing Status N/A Prescription